AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 0.656 Delayed Data As of 3:57pm ET |  -0.044 / -6.29%Today’s Change | 0.57 Today|||52-Week Range 7.60 | -70.97% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $5.2M |
Company Description
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.
Contact Information
AcelRx Pharmaceuticals, Inc. 25821 Industrial Boulevard Hayward California 94545 |
Employees
Shareholders
| Mutual fund holders | 4.01% |
| Other institutional | 13.84% |
| Individual stakeholders | 1.81% |
Top Executives
| Vincent J. Angotti | President, Chief Executive Officer & Director |
| Raffi Asadorian | Chief Financial & Accounting Officer |
| Pamela Pierce Palmer | Director & Chief Medical Officer |
| Badri N. Dasu | Chief Engineering Officer |
| Mark A. Evashenk | Vice President-Clinical Operations |
